NAD+ 1G & TIRZEPATIDE - A UK NEWS

NAD+ 1g & Tirzepatide - A UK News

The growing landscape of metabolic health in the UK is seeing increasing interest in the combination of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its analogue Tirzepatide). Specialists are observing pote

read more


A New Weight Management Hope?

Retatrutide is attracting considerable interest as a innovative treatment for weight issues . This groundbreaking medication, developed by the company , represents a major advance in weight control therapies. It works by acting like two gut hormones, GLP-1 and GIP, which affect appetite and

read more